Algeria vs Europe (WHO region): Estimated antiretroviral therapy coverage among children
Algeria
98
in 2013
Europe (WHO region)
84
in 2025
Algeria rank
1st
Europe (WHO region) rank
1st
Estimated antiretroviral therapy coverage among children over time
- Algeria
- Europe (WHO region)
How they compare
Algeria currently reports 98 against 84 in Europe (WHO region), a difference of 14.
That makes Algeria's figure about 1.2 times Europe (WHO region)'s.
The two have swapped places 1 time across 14 shared years of data; in 2000 it was Europe (WHO region) ahead.
Algeria ranks 1st and Europe (WHO region) ranks 1st of 89 countries.
Across the 2 decades both report, Algeria averaged higher in 1 and Europe (WHO region) in 1.
Head to head by decade
| Decade | Algeria | Europe (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 10.2 | 21.9 | 11.7 | Europe (WHO region) |
| 2010s | 74.25 | 42.75 | 31.5 | Algeria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher estimated antiretroviral therapy coverage among children, Algeria or Europe (WHO region)?
- Algeria, at 98 against 84 in Europe (WHO region) as of 2013.
- What is the difference in estimated antiretroviral therapy coverage among children between Algeria and Europe (WHO region)?
- 14, with Algeria ahead.
- How many years of comparable data are there for Algeria and Europe (WHO region)?
- 14 years are reported by both, from 2000 to 2013.
- How do Algeria and Europe (WHO region) rank globally for estimated antiretroviral therapy coverage among children?
- Algeria ranks 1st and Europe (WHO region) ranks 1st of 89 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Estimated antiretroviral therapy coverage among children. Statizoid refreshes it automatically from the source and publishes the full history for both places.